ALZN: Alzamend Neuro, Inc. Stock

by  •  • Comments Off on ALZN: Alzamend Neuro, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4.29
Enterprise Value ($M) 0.93
Book Value ($M) 3.45
Book Value / Share 0.52
Price / Book 1.24
NCAV ($M) 3.22
NCAV / Share 0.49
Price / NCAV 1.33

Profitability (mra)
Return on Invested Capital (ROIC) -1.23
Return on Assets (ROA) -6.69
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 5.44
Current Ratio 5.44

Balance Sheet (mrq) ($M)
Current Assets 3.95
Assets 4.18
Liabilities 0.73
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-12-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-09-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-07-30 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended April 30, 2024 ¨ TRANSITION REPORT PURSUANT TO SECTION

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 151,247 292,601 51.69
2025-05-08 107,944 268,457 40.21
2025-05-07 102,370 428,198 23.91
2025-05-06 31,124 110,092 28.27
2025-05-05 38,832 80,037 48.52

(click for more detail)

Similar Companies
ALDX – Aldeyra Therapeutics, Inc. ALGS – Aligos Therapeutics, Inc.
ALTS – JanOne Inc. ANEB – Anebulo Pharmaceuticals, Inc.
ANIX – Anixa Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io